Get started
Author

Simon Van Wambeke

Observed names: S van Wambeke, S. Van Wambeke, Van Wambeke, Simon
ORCID: 0000-0001-9802-6919
Observed ORCIDs: 0000-0001-9802-6919, 0000-0003-3062-4300
OpenAlex ID: A5084930708
Controlling the Control Arm in Metastatic Castration-Resistant Prostate Cancer Trials: Best Standard of Care or the Minimum Standard of Care?
2022 · Simon Van Wambeke, Francisco Emilio Vera-Badillo, et al. · Journal of Clinical Oncology · 21
CDK 4/6 inhibitors for adjuvant therapy in early breast cancer—Do we have a clear winner?
2022 · Amol Akhade, Simon Van Wambeke, et al. · ecancermedicalscience · 10
PDF
Atezolizumab in Metastatic Triple-Negative Breast Cancer—No Contradiction in the Eyes of a Dispassionate Observer
2021 · Simon Van Wambeke, Bishal Gyawali · JAMA Oncology · 9
Treatment of patients with newly diagnosed metastatic hormone sensitive prostate cancer (mHSPC) in Belgium: a real world data analysis
2021 · E Lambert, S Hollebosch, et al. · Acta Clinica Belgica · 7
Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19: analysis of the nationwide BSMO-COVID registry providing lessons for the future
2022 · T. Geukens, M. Brandão, et al. · ESMO Open · 5
Risk and Benefit for Basket Trials in Oncology: A Systematic Review and Meta-Analysis
2024 · Katarzyna Klas, Karolina Strzebonska, et al. · Targeted Oncology · 4
PDF
A Case of Severe Acute Cardiac Failure on Sunitinib After Left-Sided Thoracal Radiation Therapy
2016 · Ciska-Anne Van Keerberghen, Simon Van Wambeke, et al. · Clinical Genitourinary Cancer · 2
Clinical Trial Protocol for ProBio-mHSPC: A ctDNA-driven De-escalation and Intensification Platform Trial for Metastatic Hormone-sensitive Prostate Cancer
2026 · Bram De Laere, Alessio Crippa, et al. · European Urology Focus
SAVE: A multicenter randomized phase 2 trial of salvage radiotherapy (SRT) with androgen-deprivation therapy (ADT) versus apalutamide (Apa) for biochemical progression after radical prostatectomy (RP).
2026 · Piet Dirix, Peter Schatteman, et al. · Journal of Clinical Oncology
PDF
117P Risk and benefit for targeted therapy and immunotherapy agents in basket trials in oncology: A systematic review with meta-analysis
2025 · K. Strzebonska, K. Klas, et al. · ESMO Open
Short and medium-term outcomes of patients with solid cancer hospitalized with COVID-19 in Belgium according to cancer diagnosis and treatment characteristics.
2022 · Tatjana Geukens, Mariana Brandão, et al. · Journal of Clinical Oncology
Voorafgaande zorgplanning in de huisartsenpraktijk
2020 · S. Van Wambeke, G. Goderis, et al. · Tijdschrift voor Geneeskunde
Works count: 13
Citation count: 58
H-index: 5
I10-index: 2
Year
Topic
Type